Neuroprotection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-01-24

Pages: 103 Pages

Report ld: 2335191

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

Neuroprotection refers to strategies and treatments aimed at preserving the structure and function of neurons in the nervous system. It is critical for conditions like stroke and neurodegenerative diseases.

The global market for Neuroprotection was estimated to be worth US$ 23400 million in 2023 and is forecast to a readjusted size of US$ 32780 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030

Neuroprotection Market Size(US$)

M= millions and B=billions

As the aging population grows, neuroprotection research and therapies are on the rise. Potential treatments for diseases like Alzheimer's are a significant focus.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Neuroprotection, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Neuroprotection by region & country, by Type, and by Application.

The Neuroprotection market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroprotection.

Market Segmentation

Report Metric
Details
Report Title
Neuroprotection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 32780 million
CAGR(2024-2030)
4.5%
Market Size Available for Years
2024-2030
Global Neuroprotection Companies Covered
F. Hoffmann-La Roche
Eli Lilly and Company
Daiichi Sankyo Company
Allergan
Novartis
AstraZeneca
Dr. Reddy's Laboratories
Astrocyte Pharmaceuticals
Teva Pharmaceutical Industries
Biogen
Global Neuroprotection Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neuroprotection Market, Segment by Type
Free Anti-Inflammatory Agents
Radical Trapping Agents (Antioxidants)
Apoptosis Inhibitors
Glutamate Antagonists (Anti-Excitotoxic Agents)
Neurotrophic Factors (NTFs)
Stimulants
Metal Ion Chelators
Others
Global Neuroprotection Market, Segment by Application
Prevention
Treatment
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Neuroprotection manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Neuroprotection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Neuroprotection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Neuroprotection Product Introduction
    1.2 Global Neuroprotection Market Size Forecast
    1.3 Neuroprotection Market Trends & Drivers
        1.3.1 Neuroprotection Industry Trends
        1.3.2 Neuroprotection Market Drivers & Opportunity
        1.3.3 Neuroprotection Market Challenges
        1.3.4 Neuroprotection Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Neuroprotection Players Revenue Ranking (2023)
    2.2 Global Neuroprotection Revenue by Company (2019-2024)
    2.3 Key Companies Neuroprotection Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Neuroprotection Product Offered
    2.5 Key Companies Time to Begin Mass Production of Neuroprotection
    2.6 Neuroprotection Market Competitive Analysis
        2.6.1 Neuroprotection Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Neuroprotection Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroprotection as of 2023)
    2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Free Anti-Inflammatory Agents
        3.1.2 Radical Trapping Agents (Antioxidants)
        3.1.3 Apoptosis Inhibitors
        3.1.4 Glutamate Antagonists (Anti-Excitotoxic Agents)
        3.1.5 Neurotrophic Factors (NTFs)
        3.1.6 Stimulants
        3.1.7 Metal Ion Chelators
        3.1.8 Others
    3.2 Global Neuroprotection Sales Value by Type
        3.2.1 Global Neuroprotection Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Neuroprotection Sales Value, by Type (2019-2030)
        3.2.3 Global Neuroprotection Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Prevention
        4.1.2 Treatment
    4.2 Global Neuroprotection Sales Value by Application
        4.2.1 Global Neuroprotection Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Neuroprotection Sales Value, by Application (2019-2030)
        4.2.3 Global Neuroprotection Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region
    5.1 Global Neuroprotection Sales Value by Region
        5.1.1 Global Neuroprotection Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Neuroprotection Sales Value by Region (2019-2024)
        5.1.3 Global Neuroprotection Sales Value by Region (2025-2030)
        5.1.4 Global Neuroprotection Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Neuroprotection Sales Value, 2019-2030
        5.2.2 North America Neuroprotection Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Neuroprotection Sales Value, 2019-2030
        5.3.2 Europe Neuroprotection Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Neuroprotection Sales Value, 2019-2030
        5.4.2 Asia Pacific Neuroprotection Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Neuroprotection Sales Value, 2019-2030
        5.5.2 South America Neuroprotection Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Neuroprotection Sales Value, 2019-2030
        5.6.2 Middle East & Africa Neuroprotection Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Neuroprotection Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Neuroprotection Sales Value
    6.3 United States
        6.3.1 United States Neuroprotection Sales Value, 2019-2030
        6.3.2 United States Neuroprotection Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Neuroprotection Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Neuroprotection Sales Value, 2019-2030
        6.4.2 Europe Neuroprotection Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Neuroprotection Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Neuroprotection Sales Value, 2019-2030
        6.5.2 China Neuroprotection Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Neuroprotection Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Neuroprotection Sales Value, 2019-2030
        6.6.2 Japan Neuroprotection Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Neuroprotection Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Neuroprotection Sales Value, 2019-2030
        6.7.2 South Korea Neuroprotection Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Neuroprotection Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Neuroprotection Sales Value, 2019-2030
        6.8.2 Southeast Asia Neuroprotection Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Neuroprotection Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Neuroprotection Sales Value, 2019-2030
        6.9.2 India Neuroprotection Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Neuroprotection Sales Value by Application, 2023 VS 2030

7 Company Profiles
    7.1 F. Hoffmann-La Roche
        7.1.1 F. Hoffmann-La Roche Profile
        7.1.2 F. Hoffmann-La Roche Main Business
        7.1.3 F. Hoffmann-La Roche Neuroprotection Products, Services and Solutions
        7.1.4 F. Hoffmann-La Roche Neuroprotection Revenue (US$ Million) & (2019-2024)
        7.1.5 F. Hoffmann-La Roche Recent Developments
    7.2 Eli Lilly and Company
        7.2.1 Eli Lilly and Company Profile
        7.2.2 Eli Lilly and Company Main Business
        7.2.3 Eli Lilly and Company Neuroprotection Products, Services and Solutions
        7.2.4 Eli Lilly and Company Neuroprotection Revenue (US$ Million) & (2019-2024)
        7.2.5 Eli Lilly and Company Recent Developments
    7.3 Daiichi Sankyo Company
        7.3.1 Daiichi Sankyo Company Profile
        7.3.2 Daiichi Sankyo Company Main Business
        7.3.3 Daiichi Sankyo Company Neuroprotection Products, Services and Solutions
        7.3.4 Daiichi Sankyo Company Neuroprotection Revenue (US$ Million) & (2019-2024)
        7.3.5 Allergan Recent Developments
    7.4 Allergan
        7.4.1 Allergan Profile
        7.4.2 Allergan Main Business
        7.4.3 Allergan Neuroprotection Products, Services and Solutions
        7.4.4 Allergan Neuroprotection Revenue (US$ Million) & (2019-2024)
        7.4.5 Allergan Recent Developments
    7.5 Novartis
        7.5.1 Novartis Profile
        7.5.2 Novartis Main Business
        7.5.3 Novartis Neuroprotection Products, Services and Solutions
        7.5.4 Novartis Neuroprotection Revenue (US$ Million) & (2019-2024)
        7.5.5 Novartis Recent Developments
    7.6 AstraZeneca
        7.6.1 AstraZeneca Profile
        7.6.2 AstraZeneca Main Business
        7.6.3 AstraZeneca Neuroprotection Products, Services and Solutions
        7.6.4 AstraZeneca Neuroprotection Revenue (US$ Million) & (2019-2024)
        7.6.5 AstraZeneca Recent Developments
    7.7 Dr. Reddy's Laboratories
        7.7.1 Dr. Reddy's Laboratories Profile
        7.7.2 Dr. Reddy's Laboratories Main Business
        7.7.3 Dr. Reddy's Laboratories Neuroprotection Products, Services and Solutions
        7.7.4 Dr. Reddy's Laboratories Neuroprotection Revenue (US$ Million) & (2019-2024)
        7.7.5 Dr. Reddy's Laboratories Recent Developments
    7.8 Astrocyte Pharmaceuticals
        7.8.1 Astrocyte Pharmaceuticals Profile
        7.8.2 Astrocyte Pharmaceuticals Main Business
        7.8.3 Astrocyte Pharmaceuticals Neuroprotection Products, Services and Solutions
        7.8.4 Astrocyte Pharmaceuticals Neuroprotection Revenue (US$ Million) & (2019-2024)
        7.8.5 Astrocyte Pharmaceuticals Recent Developments
    7.9 Teva Pharmaceutical Industries
        7.9.1 Teva Pharmaceutical Industries Profile
        7.9.2 Teva Pharmaceutical Industries Main Business
        7.9.3 Teva Pharmaceutical Industries Neuroprotection Products, Services and Solutions
        7.9.4 Teva Pharmaceutical Industries Neuroprotection Revenue (US$ Million) & (2019-2024)
        7.9.5 Teva Pharmaceutical Industries Recent Developments
    7.10 Biogen
        7.10.1 Biogen Profile
        7.10.2 Biogen Main Business
        7.10.3 Biogen Neuroprotection Products, Services and Solutions
        7.10.4 Biogen Neuroprotection Revenue (US$ Million) & (2019-2024)
        7.10.5 Biogen Recent Developments

8 Industry Chain Analysis
    8.1 Neuroprotection Industrial Chain
    8.2 Neuroprotection Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Neuroprotection Sales Model
        8.5.2 Sales Channel
        8.5.3 Neuroprotection Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Neuroprotection Market Trends
    Table 2. Neuroprotection Market Drivers & Opportunity
    Table 3. Neuroprotection Market Challenges
    Table 4. Neuroprotection Market Restraints
    Table 5. Global Neuroprotection Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Neuroprotection Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Neuroprotection Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Neuroprotection Product Type
    Table 9. Key Companies Time to Begin Mass Production of Neuroprotection
    Table 10. Global Neuroprotection Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroprotection as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Neuroprotection Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Neuroprotection Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Neuroprotection Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Neuroprotection Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Neuroprotection Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Neuroprotection Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Neuroprotection Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Neuroprotection Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Neuroprotection Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Neuroprotection Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Neuroprotection Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Neuroprotection Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Neuroprotection Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Neuroprotection Sales Value by Region (2019-2024) & (%)
    Table 27. Global Neuroprotection Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Neuroprotection Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Neuroprotection Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Neuroprotection Sales Value, (2025-2030) & (US$ Million)
    Table 31. F. Hoffmann-La Roche Basic Information List
    Table 32. F. Hoffmann-La Roche Description and Business Overview
    Table 33. F. Hoffmann-La Roche Neuroprotection Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Neuroprotection Business of F. Hoffmann-La Roche (2019-2024)
    Table 35. F. Hoffmann-La Roche Recent Developments
    Table 36. Eli Lilly and Company Basic Information List
    Table 37. Eli Lilly and Company Description and Business Overview
    Table 38. Eli Lilly and Company Neuroprotection Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Neuroprotection Business of Eli Lilly and Company (2019-2024)
    Table 40. Eli Lilly and Company Recent Developments
    Table 41. Daiichi Sankyo Company Basic Information List
    Table 42. Daiichi Sankyo Company Description and Business Overview
    Table 43. Daiichi Sankyo Company Neuroprotection Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Neuroprotection Business of Daiichi Sankyo Company (2019-2024)
    Table 45. Daiichi Sankyo Company Recent Developments
    Table 46. Allergan Basic Information List
    Table 47. Allergan Description and Business Overview
    Table 48. Allergan Neuroprotection Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Neuroprotection Business of Allergan (2019-2024)
    Table 50. Allergan Recent Developments
    Table 51. Novartis Basic Information List
    Table 52. Novartis Description and Business Overview
    Table 53. Novartis Neuroprotection Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Neuroprotection Business of Novartis (2019-2024)
    Table 55. Novartis Recent Developments
    Table 56. AstraZeneca Basic Information List
    Table 57. AstraZeneca Description and Business Overview
    Table 58. AstraZeneca Neuroprotection Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Neuroprotection Business of AstraZeneca (2019-2024)
    Table 60. AstraZeneca Recent Developments
    Table 61. Dr. Reddy's Laboratories Basic Information List
    Table 62. Dr. Reddy's Laboratories Description and Business Overview
    Table 63. Dr. Reddy's Laboratories Neuroprotection Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Neuroprotection Business of Dr. Reddy's Laboratories (2019-2024)
    Table 65. Dr. Reddy's Laboratories Recent Developments
    Table 66. Astrocyte Pharmaceuticals Basic Information List
    Table 67. Astrocyte Pharmaceuticals Description and Business Overview
    Table 68. Astrocyte Pharmaceuticals Neuroprotection Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Neuroprotection Business of Astrocyte Pharmaceuticals (2019-2024)
    Table 70. Astrocyte Pharmaceuticals Recent Developments
    Table 71. Teva Pharmaceutical Industries Basic Information List
    Table 72. Teva Pharmaceutical Industries Description and Business Overview
    Table 73. Teva Pharmaceutical Industries Neuroprotection Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Neuroprotection Business of Teva Pharmaceutical Industries (2019-2024)
    Table 75. Teva Pharmaceutical Industries Recent Developments
    Table 76. Biogen Basic Information List
    Table 77. Biogen Description and Business Overview
    Table 78. Biogen Neuroprotection Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Neuroprotection Business of Biogen (2019-2024)
    Table 80. Biogen Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Neuroprotection Downstream Customers
    Table 84. Neuroprotection Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Neuroprotection Product Picture
    Figure 2. Global Neuroprotection Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Neuroprotection Sales Value (2019-2030) & (US$ Million)
    Figure 4. Neuroprotection Report Years Considered
    Figure 5. Global Neuroprotection Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Neuroprotection Revenue in 2023
    Figure 7. Neuroprotection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Free Anti-Inflammatory Agents Picture
    Figure 9. Radical Trapping Agents (Antioxidants) Picture
    Figure 10. Apoptosis Inhibitors Picture
    Figure 11. Glutamate Antagonists (Anti-Excitotoxic Agents) Picture
    Figure 12. Neurotrophic Factors (NTFs) Picture
    Figure 13. Stimulants Picture
    Figure 14. Metal Ion Chelators Picture
    Figure 15. Others Picture
    Figure 16. Global Neuroprotection Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Neuroprotection Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Product Picture of Prevention
    Figure 19. Product Picture of Treatment
    Figure 20. Global Neuroprotection Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Neuroprotection Sales Value Market Share by Application, 2023 & 2030
    Figure 22. North America Neuroprotection Sales Value (2019-2030) & (US$ Million)
    Figure 23. North America Neuroprotection Sales Value by Country (%), 2023 VS 2030
    Figure 24. Europe Neuroprotection Sales Value (2019-2030) & (US$ Million)
    Figure 25. Europe Neuroprotection Sales Value by Country (%), 2023 VS 2030
    Figure 26. Asia Pacific Neuroprotection Sales Value (2019-2030) & (US$ Million)
    Figure 27. Asia Pacific Neuroprotection Sales Value by Country (%), 2023 VS 2030
    Figure 28. South America Neuroprotection Sales Value (2019-2030) & (US$ Million)
    Figure 29. South America Neuroprotection Sales Value by Country (%), 2023 VS 2030
    Figure 30. Middle East & Africa Neuroprotection Sales Value (2019-2030) & (US$ Million)
    Figure 31. Middle East & Africa Neuroprotection Sales Value by Country (%), 2023 VS 2030
    Figure 32. Key Countries/Regions Neuroprotection Sales Value (%), (2019-2030)
    Figure 33. United States Neuroprotection Sales Value, (2019-2030) & (US$ Million)
    Figure 34. United States Neuroprotection Sales Value by Type (%), 2023 VS 2030
    Figure 35. United States Neuroprotection Sales Value by Application (%), 2023 VS 2030
    Figure 36. Europe Neuroprotection Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Europe Neuroprotection Sales Value by Type (%), 2023 VS 2030
    Figure 38. Europe Neuroprotection Sales Value by Application (%), 2023 VS 2030
    Figure 39. China Neuroprotection Sales Value, (2019-2030) & (US$ Million)
    Figure 40. China Neuroprotection Sales Value by Type (%), 2023 VS 2030
    Figure 41. China Neuroprotection Sales Value by Application (%), 2023 VS 2030
    Figure 42. Japan Neuroprotection Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Japan Neuroprotection Sales Value by Type (%), 2023 VS 2030
    Figure 44. Japan Neuroprotection Sales Value by Application (%), 2023 VS 2030
    Figure 45. South Korea Neuroprotection Sales Value, (2019-2030) & (US$ Million)
    Figure 46. South Korea Neuroprotection Sales Value by Type (%), 2023 VS 2030
    Figure 47. South Korea Neuroprotection Sales Value by Application (%), 2023 VS 2030
    Figure 48. Southeast Asia Neuroprotection Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Neuroprotection Sales Value by Type (%), 2023 VS 2030
    Figure 50. Southeast Asia Neuroprotection Sales Value by Application (%), 2023 VS 2030
    Figure 51. India Neuroprotection Sales Value, (2019-2030) & (US$ Million)
    Figure 52. India Neuroprotection Sales Value by Type (%), 2023 VS 2030
    Figure 53. India Neuroprotection Sales Value by Application (%), 2023 VS 2030
    Figure 54. Neuroprotection Industrial Chain
    Figure 55. Neuroprotection Manufacturing Cost Structure
    Figure 56. Channels of Distribution (Direct Sales, and Distribution)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation

Description

Neuroprotection refers to strategies and treatments aimed at preserving the structure and function of neurons in the nervous system. It is critical for conditions like stroke and neurodegenerative diseases.

The global market for Neuroprotection was estimated to be worth US$ 23400 million in 2023 and is forecast to a readjusted size of US$ 32780 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030

As the aging population grows, neuroprotection research and therapies are on the rise. Potential treatments for diseases like Alzheimer's are a significant focus.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Neuroprotection, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Neuroprotection by region & country, by Type, and by Application.

The Neuroprotection market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroprotection.

Market Segmentation

Related Reports

Global Neuroprotection Market Research Report 2023
Neuroprotection is defined as an involvement able to affect the etiology or the pathogenesis underly
Published: 2023-06-10
Pages: 86
USD 2900.00
(Single User License)
Global Neuroprotection Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
Neuroprotection is defined as an involvement able to affect the etiology or the pathogenesis underly
Published: 2023-05-30
Pages: 109
USD 5600.00
(Single User License)
Global Neuroprotection Market Insights, Forecast to 2029
Neuroprotection is defined as an involvement able to affect the etiology or the pathogenesis underly
Published: 2023-02-02
Pages: 114
USD 4900.00
(Single User License)
Global Neuroprotection Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application
Neuroprotection is defined as an involvement able to affect the etiology or the pathogenesis underly
Published: 2023-05-29
Pages: 104
USD 3350.00
(Single User License)
Neuroprotection - Global Market Insights and Sales Trends 2024
Neuroprotection is defined as an involvement able to affect the etiology or the pathogenesis underly
Published: 2023-11-13
Pages: 100
USD 3350.00
(Single User License)
Global Neuroprotection Market Research Report 2024
Neuroprotection refers to strategies and treatments aimed at preserving the structure and function o
Published: 2024-01-31
Pages: 82
USD 2900.00
(Single User License)
Global Neuroprotection Market Insights, Forecast to 2030
Neuroprotection refers to strategies and treatments aimed at preserving the structure and function o
Published: 2024-04-28
Pages: 106
USD 4900.00
(Single User License)
Global Neuroprotection Market Research Report 2025
The global market for Neuroprotection was valued at US$ 26190 million in the year 2024 and is projec
Published: 2025-02-25
Pages: 72
USD 2900.00
(Single User License)
Neuroprotection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neuroprotection was estimated to be worth US$ 26190 million in 2024 and is for
Published: 2025-02-25
Pages: 90
USD 3950.00
(Single User License)